These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38332428)

  • 1. FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence.
    Simbrunner B; Hofer BS; Schwabl P; Zinober K; Petrenko O; Fuchs C; Semmler G; Marculescu R; Mandorfer M; Datz C; Trauner M; Reiberger T
    Hepatol Int; 2024 Jun; 18(3):929-942. PubMed ID: 38332428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
    Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific mechanisms of bile acid homeostasis and activation of FXR-FGF19 signaling in preterm and term neonatal pigs.
    Vonderohe C; Guthrie G; Stoll B; Chacko S; Dawson H; Burrin DG
    Am J Physiol Gastrointest Liver Physiol; 2022 Jan; 322(1):G117-G133. PubMed ID: 34851728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
    Byun S; Kim DH; Ryerson D; Kim YC; Sun H; Kong B; Yau P; Guo G; Xu HE; Kemper B; Kemper JK
    Nat Commun; 2018 Jul; 9(1):2590. PubMed ID: 29968724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor.
    Gadaleta RM; Garcia-Irigoyen O; Cariello M; Scialpi N; Peres C; Vetrano S; Fiorino G; Danese S; Ko B; Luo J; Porru E; Roda A; Sabbà C; Moschetta A
    EBioMedicine; 2020 Apr; 54():102719. PubMed ID: 32259714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19.
    Piglionica M; Cariello M; Moschetta A
    Curr Opin Pharmacol; 2018 Dec; 43():93-98. PubMed ID: 30223181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental regulation of the intestinal FGF19 system in domestic pigs.
    Gavaldà-Navarro A; Pastor JJ; Mereu A; Villarroya F; Ipharraguerre IR
    Am J Physiol Gastrointest Liver Physiol; 2018 Jun; 314(6):G647-G654. PubMed ID: 29446652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
    Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R
    J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.
    Seok S; Kanamaluru D; Xiao Z; Ryerson D; Choi SE; Suino-Powell K; Xu HE; Veenstra TD; Kemper JK
    J Biol Chem; 2013 Aug; 288(32):23252-63. PubMed ID: 23824184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.
    Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK
    Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
    Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
    Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
    Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
    Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
    Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations.
    Cariello M; Piccinin E; Garcia-Irigoyen O; Sabbà C; Moschetta A
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1308-1318. PubMed ID: 28965883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Postnatal Upregulation of Intestinal Farnesoid X Receptor-Fibroblast Growth Factor 19 Signaling in Premature Pigs.
    Smith V; Jiang Y; Thymann T; Sangild P; Maj M; Manjarin R; Burrin D
    J Pediatr Gastroenterol Nutr; 2020 May; 70(5):e94-e99. PubMed ID: 31990866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling.
    Di Ciaula A; Bonfrate L; Baj J; Khalil M; Garruti G; Stellaard F; Wang HH; Wang DQ; Portincasa P
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease.
    Wunsch E; Milkiewicz M; Wasik U; Trottier J; Kempińska-Podhorodecka A; Elias E; Barbier O; Milkiewicz P
    Sci Rep; 2015 Aug; 5():13462. PubMed ID: 26293907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.